etherna is an RNA technology company based in Belgium, specialising in RNA chemistry and lipid nanoparticle (LNP) delivery systems for pharmaceutical and biotech partners. With over 30 years of experience, etherna supports RNA therapeutic development through innovative platforms and integrated manufacturing services.

Key Products and Services

• Proprietary LNP and mRNA chemistry platforms
• RNA manufacturing (research-grade and GMP-certified)
• Oncology-focused product pipelines
• Technology and product partnering

etherna combines pioneering expertise with flexible partnerships to drive breakthroughs in RNA therapeutics. It aims to empower healthcare innovations globally. For more information, visit etherna.